Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Maastricht University Medical Center
Age
45–99
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
postmenopausal patients with hormone receptor positive breast cancer who have already received 2 to 3 years of adjuvant tamoxifen, and who never had signs of loco-regional recurrences or distant metastasis
You may not be if
Previous hormonal therapy as adjuvant breast cancer treatment besides tamoxifen.
Previous history of invasive breast cancer within the last 10 years, other then the breast cancer that is currently treated with tamoxifen
Clareo Health | Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
